Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Administering an exam used to be straightforward: All a college professor needed was an open room and a stack of blue books. At many American universities, this is no longer true. Professors now ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Kate Fitz-Gibbon has received funding for research on violence against women and children from a range of federal and state government and non-government sources, including Australia's National ...
On Nov. 2, Alaskans will again “fall back” as we return to Alaska Standard Time. We’ll reset clocks, enjoy an extra hour of sleep, and for a moment, ask the same question we always do: Why are we ...
It's a well-known fact that quantum calculations are difficult, but one would think that quantum computers would facilitate the process. In most cases, this is true. Quantum bits, or qubits, use ...
In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...
NEW YORK, Oct 3 (Reuters) - The release of U.S. jobs data typically has traders and investors glued to their screens at 8:30 am waiting for the all-important numbers. This Friday, however, is giving ...